Petpharma
Petpharma is South Korea's largest B2B e-commerce platform for veterinary pharmaceuticals, serving 6,385+ animal pharmacies with a curated catalog of 34+ pet medicines under exclusive distribution agreements with multiple Korean pharma manufacturers.
- Company typePrivate
- Founded2019
- HeadquartersSeongnam, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingDigital Commerce or Content
What Petpharma does
Petpharma Co., Ltd (주식회사 펫팜) operates South Korea's largest B2B e-commerce platform dedicated to veterinary pharmaceuticals and pet health products. Founded in December 2019 and headquartered in Seongnam-si, Gyeonggi-do, the company runs a pharmacy-exclusive online marketplace serving more than 6,385 member animal pharmacies across the country. The platform carries a curated catalog of 34+ pet medicine SKUs spanning dewormers, heartworm preventives, gastrointestinal, dermatological, ophthalmic, otic, and joint/anti-inflammatory products. Beyond distribution, the company operates a pet-owner-facing pharmacy finder and app that drives demand pull-through to member pharmacies, creating a multi-sided ecosystem that also includes veterinarians on the supply-and-recommendation side.
The company's core technology is a B2B e-commerce platform with an integrated logistics center, location-based pharmacy finder, and digital product catalog. Revenue is generated through transactions on the marketplace — selling pet medicines and health products to member animal pharmacies under exclusive distribution agreements with multiple Korean pharmaceutical manufacturers including IglVet, Kyungbo Pharmaceutical, Kwongdong Pharmaceutical, and BMSmile. In 2025, Petpharma obtained a manufacturing business license for animal pharmaceuticals, indicating a planned vertical extension from pure distribution into own-brand manufacturing. The company is a full member of the Korean Animal Drug Association.
Petpharma is venture-backed with cumulative disclosed investment exceeding 7.7 million USD across seed, pre-A, Series A, and Series B rounds between 2021 and 2025, supplemented by two government TIPS grants. Korea Investment Partners led the 2023 Series A and CRIT Ventures led the 2025 Series B. The company is led by CEO Yoon Seong-han. Its go-to-market combines channel-led distribution through the pharmacy network with product-led growth on the consumer side via the pharmacy finder, targeting both B2B (SMB pharmacies) and B2C (pet owners and veterinarians) segments.
Petpharma firmographics
Firmographics- Name
- Petpharma
- Legal name
- Pet Pharm Co., Ltd ( 주식회사 펫팜 )
- Website
- https://petpharm.kr
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Petpharma is South Korea's largest B2B e-commerce platform for veterinary pharmaceuticals, serving 6,385+ animal pharmacies with a curated catalog of 34+ pet medicines under exclusive distribution agreements with multiple Korean pharma manufacturers.
- Ownership category
- akta.pro rank
Petpharma industry classification
Industry- Product category
- Veterinary Pharmaceutical Distribution
- NAICS
- Pharmacies and Drug Retailers (45611)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)
- akta.pro secondary industries
- Online Veterinary Pharmacies & E-commerce Retailers (HLAMAIAF), Pet Pharmaceuticals & Veterinary Supply Distribution (CRAOAKAD), Veterinary Inventory, Pharmacy & Medication Management (HLAMAMAF)
Keywords
Where Petpharma is headquartered
LocationHeadquarters
- HQ city
- Seongnam
- HQ country
- South Korea
- HQ region
- Asia
Offices2 records
Markets served
Petpharma business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- B2B E-commerce Sales: Revenue generated from selling pet medicines and health products to member animal pharmacies through the B2B online platform
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Petpharma product offering
Product offeringCore offering
Petpharma operates a B2B e-commerce marketplace that supplies veterinary medicines and pet health products to licensed animal pharmacies across South Korea through a pharmacy-exclusive online platform. Member pharmacies can order from a curated catalog of 34+ veterinary SKUs (covering dewormers, heartworm preventives, gastrointestinal, dermatology, and joint medications), fulfilled from an integrated logistics center in Seongnam-si. A secondary pharmacy finder service directs pet owners to nearby member pharmacies carrying Petpharma products.
Product overview
Petpharma operates as a B2B e-commerce platform for animal pharmacies in South Korea, offering a comprehensive portfolio of 34+ veterinary medicines and health products. The platform connects animal pharmacies with pharmaceutical suppliers, enabling pharmacies to source products efficiently. The product range includes all-in-one dewormers (심피드 독, 심피드 캣, 셀라이트), heartworm preventives (하트세이버, 프리벤하트), internal dewormers (파라캅), external dewormers (가드닐, 플레복스 플러스), gastrointestinal/motion sickness medicine (멕스탑 겔), dermatological products (새로나 크림), and joint/anti-inflammatory medications (보네티 츄어블). The platform also includes a pharmacy locator service helping pet owners find nearby animal pharmacies carrying Petpharma products.
Differentiator
Problem solved
Functional benefit
Products and services
- Petpharma B2B Animal Pharmacy E-commerce Platform (펫팜 동물약국 전용 B2B몰) Pharmacy-exclusive B2B online marketplace where licensed animal pharmacies in South Korea can purchase veterinary medicines and pet health products from Petpharma's catalog of 34+ SKUs. Serves as the company's core revenue-generating product, connecting 6,385+ member pharmacies with pet pharmaceutical suppliers nationwide.
- Petpharma Pharmacy Finder (약국찾기) Location-based service that helps pet owners locate nearby animal pharmacies carrying Petpharma products. Supports demand pull-through to member pharmacies by directing pet owner inquiries to stocking locations.
- Simpiddog (심피드 독) - All-in-one Dewormer for Dogs (3P) All-in-one dewormer (올인원 구충제) for dogs providing comprehensive internal and external parasite protection. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Simpid Cat (심피드 캣) - All-in-one Dewormer for Cats (3P) All-in-one dewormer (올인원 구충제) for cats providing comprehensive internal and external parasite protection. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Mecstop Gel (멕스탑 겔) - Pet Stomach/Motion Sickness Medicine (8-count) Gastrointestinal and motion sickness medicine (위장/멀미약) for pets in 8-count gel pack. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Saerona Cream (새로나 크림) - Pet Skin Medicine/Shampoo (10g) Dermatological cream (피부약/샴푸) for pets in 10g tube. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Bonetti Chewable (보네티 츄어블) - Pet Joint Medicine/Anti-inflammatory (12-count) Joint and anti-inflammatory chewable (관절약/소염제) for pets in 12-count pack. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Selight (셀라이트) - All-in-one Dewormer for Dogs & Cats (3P) All-in-one dewormer (올인원 구충제) for both dogs and cats in 3-pack. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Guardnil (가드닐) - External Dewormer for Pets (3P) External dewormer (외부 구충제) for pets in 3-pack. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Heartsaver Chewable (하트세이버 츄어블) - Heartworm Prevention (6T) Heartworm preventive (심장사상충약) in chewable tablet form (6 tablets) for dogs. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Heartsaver Tablet (하트세이버 정) - Heartworm Prevention (10T) Heartworm preventive (심장사상충약) in tablet form (10 tablets). Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Prevenheart Chewable (프리벤하트 츄어블) - Heartworm Prevention (6T) Heartworm preventive (심장사상충약) in chewable tablet form (6 tablets). Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Flevox Plus (플레복스 플러스) - External Dewormer/Flea & Tick Treatment (3P) External dewormer (외부 구충제) for flea and tick treatment in 3-pack. Sold through Petpharma's B2B platform to licensed animal pharmacies.
- Paracop (파라캅 정) - Internal Dewormer (6T) Internal dewormer (내부 구충제) in tablet form (6 tablets). Sold through Petpharma's B2B platform to licensed animal pharmacies.
Quantifiable outcome
- Supplies pet medicines and health products to over 6,385 pharmacies across South Korea
- +1 more outcomes
Companies that use Petpharma
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Petpharma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Petpharma partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Korean Animal Drug Association (한국동물약품협회)coreFull membership in the Korean Animal Drug Association, the industry's primary industry body, indicating recognition and regulatory standing.
- IglVet (이글벳)coreExclusive supply agreement for IglVet products. Petpharma serves as the exclusive distributor for IglVet's pet pharmaceutical products in Korea.
- Kyungbo Pharmaceutical (경보제약)coreExclusive supply partnership for Kyungbo Pharmaceutical's pet medicine products. Kyungbo is a major Korean pharmaceutical company.
- Kwongdong Pharmaceutical (광동제약)coreExclusive supply agreement for Kwongdong Pharmaceutical's pet health products.
- BMSmile (비엠스마일)minorExclusive supply partnership for BMSmile pet health products.
- Various Pharmaceutical PartnerscorePartnership portfolio includes Eagle Vet, Breezy Tail, Pet Room, Thank Pets, Choongangbio, Kwangdong, and VetoBe for product distribution.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Petpharma competitors and assessment
Company assessmentBroad incumbents
- Vetoquinol: Global animal-health pharmaceutical company with a strong parasiticides and specialty care portfolio distributed through veterinary channels. Comparable supplier/competitor dynamic in the same animal-pharma product categories.
- Elanco Animal Health: Global animal-health manufacturer of parasiticides, vaccines, and therapeutics sold through veterinary distribution. Comparable as both a potential supplier to Petpharma and a competitor that could build or use captive distribution in Korea.
- Chewy Pharmacy: Online pet pharmacy operated by Chewy, dispensing prescription and OTC pet medications to US consumers. Comparable online animal pharmacy retail channel, though primarily B2C rather than Petpharma's B2B-pharmacy model.
- Covetrus (now part of Henry Schein Animal Health): Global veterinary distribution and practice solutions provider offering pharma distribution, software, and services to animal-health practices. Comparable as a scaled veterinary pharmaceutical wholesaler/distributor serving fragmented SMB customers.
- 1-800-PetMeds (PetCareRx): Long-established online pet pharmacy retailer selling prescription and OTC pet medications. Comparable as an established pet pharma e-commerce/retail brand in the same end-product category.
Direct peers
- Vetsource: US veterinary pharmacy and distribution platform providing home delivery of pet medications and pharmacy management tools to veterinary practices. Directly comparable B2B veterinary pharma distribution and pharmacy-services model.
- Vetcove: US-based B2B online marketplace where veterinary practices purchase medications and supplies from multiple manufacturers. Closely comparable model to Petpharma's pharmacy-exclusive B2B platform, with the same multi-supplier marketplace structure and SMB veterinary buyer base.
Regional players
- Komipharm International: South Korean animal-health pharmaceutical manufacturer and distributor. Most directly comparable Korean peer for animal pharma manufacturing and domestic distribution overlap with Petpharma's supplier set.
- Daewoong Pharmaceutical (Animal Health Division): Major Korean pharmaceutical group with an animal-health business covering veterinary medicines and supplements. Comparable Korean animal-pharma manufacturer that could compete with or supply Petpharma.
Emerging players
- Pattern (animal-health inventory platform): Emerging veterinary inventory and procurement platform serving veterinary practices with supply management. Comparable emerging B2B infrastructure play addressing similar pharmacy/practice supply workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Petpharma social profiles
Digital presencePetpharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Petpharma leadership team
Management profileNumber of profiles
Profiles2 records
Petpharma funding detail
Funding detailFunding overview
Funding rounds5 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Petpharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Petpharma
What does Petpharma do?
Petpharma operates a B2B e-commerce marketplace that supplies veterinary medicines and pet health products to licensed animal pharmacies across South Korea through a pharmacy-exclusive online platform. Member pharmacies can order from a curated catalog of 34+ veterinary SKUs (covering dewormers, heartworm preventives, gastrointestinal, dermatology, and joint medications), fulfilled from an integrated logistics center in Seongnam-si. A secondary pharmacy finder service directs pet owners to nearby member pharmacies carrying Petpharma products.
Is Petpharma a public or private company?
Petpharma is a private company. It is classified as venture growth investor backed and is currently operating.
When was Petpharma founded?
Petpharma was founded in 2019. It employs 11 to 50 people.
Where is Petpharma based?
Petpharma is headquartered in Seongnam, South Korea, in the Asia region.
How does Petpharma make money?
One revenue line is on record: B2B E-commerce Sales.
Who are Petpharma's main competitors?
Broad incumbents on record are Vetoquinol, Elanco Animal Health, Chewy Pharmacy, Covetrus (now part of Henry Schein Animal Health) and 1-800-PetMeds (PetCareRx). Direct peers are Vetsource and Vetcove. Regional players are Komipharm International and Daewoong Pharmaceutical (Animal Health Division). Pattern (animal-health inventory platform) is listed as an emerging player.
Does Petpharma have an API?
No public API is recorded for Petpharma.
What industry is Petpharma in?
Petpharma's product category is Veterinary Pharmaceutical Distribution. Its primary akta.pro industry code is HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors, with a secondary code of HLAMAIAF, Online Veterinary Pharmacies & E-commerce Retailers. Its NAICS code is 45611 and its SIC code is 5122.